374
Views
34
CrossRef citations to date
0
Altmetric
Original Articles

Pyromellitic dianhydride crosslinked cyclodextrin nanosponges for curcumin controlled release; formulation, physicochemical characterization and cytotoxicity investigations

, ORCID Icon, , &
Pages 715-727 | Received 18 Jun 2019, Accepted 14 Sep 2019, Published online: 27 Sep 2019

References

  • Aggarwal, B.B., Kumar, A., and Bharti, A.C., 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer research, 23(1A), 363–398.
  • Allahyari, S., et al., 2019. Cyclodextrin-based nanosponges as promising carriers for active agents. Expert opinion on drug delivery, 16(5), 467–479.
  • Amanlou, N., et al., 2019. Enhanced cytotoxic activity of curcumin on cancer cell lines by incorporating into gold/chitosan nanogels. Materials chemistry and physics, 226, 151–157.
  • Anand, P., et al., 2007. Bioavailability of curcumin: problems and promises. Molecular pharmaceutics, 4(6), 807–818.
  • Anandam, S., and Selvamuthukumar, S., 2014. Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects. Journal of materials science, 49(23), 8140–8153.
  • Ansari, K.A., et al., 2011. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. Aaps pharmscitech, 12(1), 279–286.
  • Assadi, Z., Emtiazi, G., and Zarrabi, A., 2018. Novel synergistic activities of tetracycline copper oxide nanoparticles integrated into chitosan micro particles for delivery against multiple drug resistant strains: generation of reactive oxygen species (ROS) and cell death. Journal of drug delivery science and technology, 44, 65–70.
  • Barzegar-Jalali, M., et al., 2008. Kinetic analysis of drug release from nanoparticles. Journal of pharmacy and pharmaceutical sciences, 11(1), 167–177.
  • Baum, L., et al., 2008. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. Journal of clinical psychopharmacology, 28(1), 110–113.
  • Bhatia, S., 2016. Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. In: Bhatia S. eds. Natural polymer drug delivery systems. Switzerland: Springer, 33–93.
  • Bose, R.J., Lee, S.-H., and Park, H., 2016. Biofunctionalized nanoparticles: an emerging drug delivery platform for various disease treatments. Drug discovery today, 21(8), 1303–1312.
  • Boyanapalli, S.S., and Kong, A.-N.T., 2015. Curcumin, the king of spices: epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases. Current pharmacology reports, 1(2), 129–139.
  • Campos, C.A., et al., 2013. Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicity. Bioorganic & medicinal chemistry letters, 23, 6874–6878.
  • Chime, S., Onunkwo, G., and Onyishi, I., 2013. Kinetics and mechanisms of drug release from swellable and non swellable matrices: a review. Research journal of pharmaceutical, biological and chemical sciences, 4, 97–103.
  • Darandale, S., and Vavia, P., 2013. Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization. Journal of inclusion phenomena and macrocyclic chemistry, 75(3-4), 315–322.
  • Deshmukh, K., and Shende, P., 2018. Toluene diisocyanate cross-linked β-cyclodextrin nanosponges as a pH-sensitive carrier for naproxen. Materials research express, 5(7), 075008.
  • Ferro, M., et al., 2014. Anomalous diffusion of Ibuprofen in cyclodextrin nanosponge hydrogels: an HRMAS NMR study. Beilstein journal of organic chemistry, 10, 2715–2723.
  • Gupta, S.C., Kismali, G., and Aggarwal, B.B., 2013. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors, 39(1), 2–13.
  • Hamzehzadeh, L., et al., 2018. The versatile role of curcumin in cancer prevention and treatment: a focus on PI3K/AKT pathway. Journal of cellular physiology, 233(10), 6530–6537.
  • Hewlings, S.J., and Kalman, D.S., 2017. Curcumin: a review of its’ effects on human health. Foods, 6(10), 92.
  • Imanifard, S., et al., 2017. Nanoengineered Thermoresponsive Magnetic Nanoparticles for Drug Controlled Release. Macromolecular chemistry and physics, 218(23), 1700350.
  • Islami, M., et al., 2018. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide. International journal of nanomedicine, 13, 6059.
  • Jahed, V., et al., 2014. NMR (1H, ROESY) spectroscopic and molecular modelling investigations of supramolecular complex of β-cyclodextrin and curcumin. Food chemistry, 165, 241–246.
  • Kashi, T.S.J., et al., 2012. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. International journal of nanomedicine, 7, 221–234.
  • Kayani, Z., Firuzi, O., and Bordbar, A.-K., 2018. Doughnut-shaped bovine serum albumin nanoparticles loaded with doxorubicin for overcoming multidrug-resistant in cancer cells. International journal of biological macromolecules, 107, 1835–1843.
  • Khorrami, S., et al., 2018. Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties. International journal of nanomedicine, 13, 8013.
  • Kurkov, S.V., and Loftsson, T., 2013. Cyclodextrins. International journal of pharmaceutics, 453(1), 167–180.
  • Lao, C.D., et al., 2006. Dose escalation of a curcuminoid formulation. BMC complementary and alternative medicine, 6(1), 10.
  • Lembo, D., Trotta, F., and Cavalli, R., 2018. Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives. Nanomedicine, 13(5), 477–480.
  • Maheshwari, R.K., et al., 2006. Multiple biological activities of curcumin: a short review. Life sciences, 78(18), 2081–2087.
  • Mousavi, H., et al., 2015. A multifunctional hierarchically assembled magnetic nanostructure towards cancer nano-theranostics. RSC advances, 5(94), 77255–77263.
  • Moya-Ortega, M.D., et al., 2012. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. International journal of pharmaceutics, 428(1-2), 152–163.
  • Nelson, K.M., et al., 2017. The essential medicinal chemistry of curcumin: miniperspective. Journal of medicinal chemistry, 60(5), 1620–1637.
  • Pochampally, R., et al., 2017. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine in cancer, 8(4), 440–452.
  • Pushpalatha, R., Selvamuthukumar, S., and Kilimozhi, D., 2018. Cross-linked, cyclodextrin-based nanosponges for curcumin delivery-physicochemical characterization, drug release, stability and cytotoxicity. Journal of drug delivery science and technology, 45, 45–53.
  • Rao, T.S., Basu, N., and Siddiqui, H., 2013. Anti-inflammatory activity of curcumin analogues. Indian journal of medical research, 137, 841–845.
  • Rauf, A., et al., 2018. Health perspectives of a bioactive compound curcumin: a review. Trends in food science & technology, 74, 33–45.
  • Ravindran, J., Prasad, S., and Aggarwal, B.B., 2009. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? The AAPS journal, 11(3), 495–510.
  • Rezaei, A., et al., 2019. Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges. International journal of nanomedicine, 14, 4589.
  • Saokham, P., et al., 2018. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules, 23(5), 1161–1176.
  • Sareen, R., et al., 2014. Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation. BioMed research international, 2014, 1.
  • Shende, P., and Gaud, R., 2009. Formulation and comparative characterization of chitosan, gelatin, and chitosan–gelatin-Coated Liposomes of CPT-11–HCl. Drug development and industrial pharmacy, 35(5), 612–618.
  • Shende, P., et al., 2015. Acute and repeated dose toxicity studies of different β‐cyclodextrin‐based nanosponge formulations. Journal of pharmaceutical sciences, 104(5), 1856–1863.
  • Sherje, A.P., et al., 2017. Cyclodextrin-based nanosponges: a critical review. Carbohydrate polymers, 173, 37–49.
  • Simionato, I., et al., 2019. Encapsulation of cinnamon oil in cyclodextrin nanosponges and their potential use for antimicrobial food packaging. Food and chemical toxicology, 132, 110647.
  • Singireddy, A., and Subramanian, S., 2016. Cyclodextrin nanosponges to enhance the dissolution profile of quercetin by inclusion complex formation. Particulate science and technology, 34(3), 341–346.
  • Tejashri, G., Amrita, B., and Darshana, J., 2013. Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta pharmaceutica, 63(3), 335–358.
  • Trotta, F., and Mele, A., 2019. Nanosponges: Synthesis and Applications. Weinheim, Germany: Wiley-VCH.
  • Trotta, F., 2011. Cyclodextrin nanosponges and their applications. In: E. Bilensoy, ed. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine: Current and future industrial applications, Hoboken, NJ: John Wiley & Sons, 323–342.
  • Trotta, F., et al., 2014. Synthesis and characterization of a hyper-branched water-soluble β-cyclodextrin polymer. Beilstein journal of organic chemistry, 10, 2586.
  • Trotta, F., Tumiatti, W. & Vallero, R. 2004. Nanospugne a base di ciclodestrine funzionalizzate con gruppi carbossilici: sintesi e utilizzo nella decontaminazione da metalli pesanti e da composti organici. Italian Patent No. MI2004A000614. 2004-03-30.
  • Trotta, F., Zanetti, M., and Cavalli, R., 2012. Cyclodextrin-based nanosponges as drug carriers. Beilstein journal of organic chemistry, 8, 2091–2099.
  • Vallianou, N.G., et al., 2015. Potential anticancer properties and mechanisms of action of curcumin. Anticancer research, 35(2), 645–651.
  • Vishwakarma, A., et al., 2014. Review on nanosponges: a benefication for novel drug delivery. International journal of PharmTech research, 6, 11–20.
  • Wang, Y., et al., 2018. Nanomaterials for cancer precision medicine. Advanced materials, 30(17), 1705660.
  • Wright, J.S., 2002. Predicting the antioxidant activity of curcumin and curcuminoids. Journal of molecular structure: theochem, 591(1–3), 207–217.
  • Zarrabi, A., et al., 2011. Design and synthesis of novel polyglycerol hybrid nanomaterials for potential applications in drug delivery systems. Macromolecular bioscience, 11(3), 383–390.
  • Zarrabi, A., et al., 2014. In vitro biocompatibility evaluations of hyperbranched polyglycerol hybrid nanostructure as a candidate for nanomedicine applications. Journal of materials science: materials in medicine, 25, 499–506.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.